US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist
  • 5.530
  • +0.150+2.79%
Close Oct 16 16:00 ET
  • 5.620
  • +0.090+1.63%
Post 20:02 ET
238.60MMarket Cap-2603P/E (TTM)

Kyverna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kyverna Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Kyverna Therapeutics Earnings Reports

  • Kyverna Therapeutics | 10-Q: Quarterly report

    Aug 12 16:22 ET

  • Kyverna Therapeutics | 10-Q: Quarterly report

    May 14 16:35 ET

  • Kyverna Therapeutics | 10-K: FY2023 Annual Report

    Mar 26 16:45 ET

    • Analysis

    Analyst Rating

    Updated: Oct 11, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data